Table 1 Baseline characteristics

From: Electrocardiogram findings at the initiation of hemodialysis and types of subsequent cardiovascular events

Variables

N = 618

Age (year)

65 ± 14

Male (%)

70

eGFR (mL/min/1.73 m2)

5.1 ± 2.5

BMI (kg/m2)

23.9 ± 4.6

Systolic blood pressure (mmHg)

147 ± 24

Current smoker (%)

17

Past smoker (%)

29

Never smoker (%)

51

Unknown status of smoking (%)

2

Comorbidities

 Diabetes (%)

47

 Coronary artery disease (%)

10

 Heart failure (%)

13

 Atrial fibrillation (%)

3

 Ablation (%)

1

 Pacemaker replacement (%)

0.5

 Peripheral artery disease (%)

7

 Cerebrovascular infarction (%)

9

 Cerebrovascular hemorrhage (%)

3

 Corrected calcium (mg/dL)

8.7 ± 0.8

 Potassium (mEq/L)

4.5 ± 0.7

 Phosphate (mg/dL)

5.7 ± 1.6

 Magnesium (mg/dL)

2.3 ± 0.5

Prescription

 Dihydropyridine CCB (%)

87

 Non-dihydropyridine CCB (%)

2

 β-blocker (%)

35

 RAS inhibitors (%)

54

 Diuretics (%)

67

 Insulin (%)

19

  1. Data are presented as mean ± SD, or percentages
  2. BMI body mass index, CCB calcium channel blocker, eGFR estimated glomerular filtration rate, RAS renin angiotensin aldosterone system